General Information of the Compound
| Compound ID |
CP0408435
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-[4-[4-(8-hydroxy-2-oxo-1H-quinolin-5-yl)piperazin-1-yl]butoxy]pyrazolo[1,5-a]pyridine-3-carbaldehyde
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H27N5O4
|
||||||||||||||||||
| Molecular Weight |
461.522
|
||||||||||||||||||
| Canonical SMILES |
Oc1ccc(N2CCN(CCCCOc3ccn4ncc(C=O)c4c3)CC2)c2ccc(=O)[nH]c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H27N5O4/c31-17-18-16-26-30-9-7-19(15-22(18)30)34-14-2-1-8-28-10-12-29(13-11-28)21-4-5-23(32)25-20(21)3-6-24(33)27-25/h3-7,9,15-17,32H,1-2,8,10-14H2,(H,27,33)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NHLHTGDNMWUOMW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01169, D(1B) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor